Equities

UFP Technologies Inc

UFP Technologies Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)354.86
  • Today's Change16.88 / 4.99%
  • Shares traded40.52k
  • 1 Year change+122.48%
  • Beta0.9423
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments5.264.4511
Total Receivables, Net665539
Total Inventory705433
Prepaid expenses3.433.243.38
Other current assets, total------
Total current assets14511687
Property, plant & equipment, net767166
Goodwill, net113113108
Intangibles, net646868
Long term investments------
Note receivable - long term------
Other long term assets0.473.641.10
Total assets404378334
LIABILITIES
Accounts payable222011
Accrued expenses252615
Notes payable/short-term debt000
Current portion long-term debt/capital leases4.064.064.06
Other current liabilities, total6.626.365.16
Total current liabilities585635
Total long term debt285171
Total debt325575
Deferred income tax0.430.453.26
Minority interest------
Other liabilities, total313331
Total liabilities118141140
SHAREHOLDERS EQUITY
Common stock0.080.080.08
Additional paid-in capital393634
Retained earnings (accumulated deficit)248203161
Treasury stock - common(0.59)(0.59)(0.59)
Unrealized gain (loss)------
Other equity, total0.27(0.61)--
Total equity286238194
Total liabilities & shareholders' equity404378334
Total common shares outstanding7.647.587.54
Treasury shares - common primary issue0.030.030.03
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.